STIP1 expression, through survival pathways and MMP activation, could contribute to invasion in the highly invasive Clone #3 pancreatic cancer cell line, therefore making it a potentially valuable target for pancreatic cancer therapy. The gene discussed is STIP1; the disease is familial pancreatic carcinoma.